Guy is a General Partner at Pitango.
Prior to joining Pitango, Guy was the President & CEO of Brainsway [TLV: BRIN]. Prior to that, he served as the President & CEO of Marval Pharma, a clinical stage company, developing innovative contrast agents for use in X-ray and Computed Tomography (CT) Imaging.
Guy was the President and CEO of Ventor Technologies, a Pitango portfolio company and developer of revolutionary trans-catheter valves for the Cardiology market. Ventor was acquired by Medtronic [NYSE: MDT] in 2009.
Following the acquisition, Guy was appointed General-Manager/Vice President at Medtronic.
Prior to joining Ventor and before returning to Israel, Guy was a Senior Executive at the Pittsburgh headquarters of Medrad, Inc., a wholly owned subsidiary of Bayer Healthcare [FWB: BAYN] .
Guy holds an M.D. from Ben-Gurion University of the Negev and an MBA (cum laude) from the University of Pittsburgh.